Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Market Pulse: Shift from Non-Defense to Defense R&D Detailed

By R&D Editors | March 20, 2017

The R&D Index: Market Watch for the week ending March 17, 2017 closed at 1,645.28 for the 25 companies in the R&D Index. The Index was up 0.08% (or 1.33 basis points) over the week ending March 10, 2017. Eleven R&D Index companies gained value last week from 0.09% (Bayer AG) to 6.98% (Oracle). Fourteen R&D Index companies lost value last week from -0.03% (Honda) to -3.48% (Bristol-Myers Squibb).

For the second time in the past three months, the Federal Reserve raised short-term interest rates last Wednesday from 0.75% to 1.00%. They also noted that two more rate increases could be expected this year with an end of the year rate of approximately 1.50%. It also was noted that the inflation rate was already approaching the Fed’s target of 2.0%. The Fed noted, however, that 2.0% was not a ceiling and inflation could go slightly higher for a short period of time without any negative effects.

The Trump administration also released its FY2017 government spending proposal last Thursday with significant cuts in most agency budgets ranging from 10% to 20%. If approved by Congress, these cuts could see substantial reductions in the government’s investments in R&D. Reductions (from FY2016 budgets) were proposed for the NIH (-19.8%), DOE (-11%), DOC/NIST (-10%), the EPA (-30%), the USGS (-10%) and NASA (-1%).  Congressional comments to these proposals followed mostly party lines with Democrats taking issue with specific cuts for science agencies and Republicans mostly embracing the cuts as a means to reduce the size of government. The administration was looking to cut about funding from the non-defense discretionary budget and shift it over to the defense budget.

The NIH’s budget reduction is particularly painful for the U.S. R&D community in that most of its funding is focused on supplying grants for life science research or supporting its research centers. NIH R&D funding has been mostly static for more than 10 years, which when accounting for inflation has seen a real-dollar reduction of more than 20% alone. Adding the FY2017 proposal into this relationship, would reduce NIH R&D by more than 40% from what was invested 10 years ago in real dollar spending values.

R&D Index member Apple announced—in China only—that it plans to open two new R&D centers in China—Shanghai and Suzhou—adding to its existing R&D centers in Beijing and Shenzhen (announced earlier). These efforts are in response to its 17% drop in Chinese sales over the past year to $48.5 billion, much of it to China’s Huawei Technologies, Oppo and Vivo, each of whom ship more products that does Apple. The new R&D centers are expected to boost Apple’s annual R&D investments in China to more than $500 million—it’s total global R&D investment in 2017 is expected to exceed $9 billion. Apple stock rose 0.55% last week to close at nearly $140. If Trump’s tax repatriation succeeds this year, analysts expect Apple stock could reach $175—Apple currently has invested more than $204 billion in offshore profits.

      R&D Index Week Ending March 17, 2017      
    Ticker Exchange 2015 R&D billions$ 03/10/17 03/17/17 3/17/17 to 3/10/17 3/17/17 to 1/1/16
1 Microsoft MSFT NASDAQ 12,448 64.93 64.87 -0.09% 16.93%
2 Intel INTC NASDAQ 12,128 35.91 35.27 -1.78% 2.38%
3 Roche Pharm RHHBY OTC 10,242 32.04 31.72 -1.00% -7.98%
4 Toyota TM NYSE 9,112 112.66 112.21 -0.40% -8.80%
5 Johnson & Johnson JNJ NYSE 9,046 126.21 128.06 1.47% 24.67%
6 Novartis NVS NYSE 8,935 75.60 75.55 -0.07% -12.23%
7 Apple AAPL NASDAQ 8,397 139.14 139.91 0.55% 32.92%
8 Pfizer PFE NYSE 7,690 34.11 34.32 0.62% 5.96%
9 General Motors GM NYSE 7,500 36.83 36.33 -1.36% 6.82%
10 Merck & Co. MRK NYSE 6,704 65.60 63.90 -2.59% 20.98%
11 Ford Motor F NYSE 6,700 12.53 12.48 -0.40% -11.43%
12 Cisco CSCO NASDAQ 6,411 34.26 34.23 -0.09% 26.03%
13 Oracle ORCL NYSE 6,042 42.68 45.66 6.98% 24.99%
14 Astra Zeneca PLC AZN NYSE 5,997 29.55 30.69 3.86% -9.60%
15 Honda HMC NYSE 5,990 31.05 31.04 -0.03% -2.79%
16 Bristol-Myers Squibb BMY NYSE 5,920 58.32 56.29 -3.48% -18.18%
17 Qualcomm QCOM NASDAQ 5,833 58.64 57.55 -1.86% 15.15%
18 Sanofi SA SNY NYSE 5,519 43.91 44.30 0.89% 3.87%
19 Eli Lilly Co LLY NYSE 5,331 84.36 83.96 -0.47% -0.33%
20 GlaxoSmithKline GSK NYSE 5,250 41.37 42.27 2.18% 4.76%
21 IBM IBM NYSE 5,247 177.83 175.65 -1.23% 27.67%
22 Daimler DDAIY OTC 5,169 70.00 71.16 1.66% -8.65%
23 Siemens SIE XETRA 4,929 123.05 124.35 1.06% 38.35%
24 Bayer AG BAYN XETRA 4,649 106.75 106.85 0.09% -8.05%
25 Ericsson ERIC NASDAQ 4,124 6.62 6.66 0.60% -30.70%
      Total 175,313 1643.95 1645.28 0.08% 8.13%
                 
      Biopharmaceutical 697.82 697.91 0.01% 0.47%
      Automotive 263.07 263.22 0.06% -6.32%
      ICT   553.39 553.14 -0.05% 23.90%

 

Related Articles Read More >

Hands-on with Patsnap’s Eureka Scout: Strong features meet evolving AI backbone
Trump blocks new Harvard visas after $3 billion in frozen research funds
lab workers
‘Big Beautiful Bill Act’ proposes restoring full R&D expensing for 2025-2029
NSF caps indirect costs at 15% for new university grants
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE